Questions that recur
GHK-Cu questions on skin, hair and safety
The answer often changes when the question names a particular outcome, preparation or route.
GHK-Cu skin tightening: timing
The small topical studies collected in the skin review followed skin changes over weeks and sometimes a few months. They assessed outcomes such as firmness, density and wrinkles. Those study periods give context for the reported findings; they establish no reliable countdown for an individual. I would be sceptical of a precise day attached to ‘tighter skin’ without a specified measurement.
Does copper peptide regrow hair?
The 6-month trial in 45 men reported increased hair counts with 5-aminolevulinic acid plus GHK. That combination result leaves efficacy and timing for pure GHK-Cu unresolved. The animal follicle findings add a research rationale; the human trial still concerns its particular preparation.
Is copper peptide safe?
Topical Copper Tripeptide-1 is a legal cosmetic ingredient in the US, EU and UK. GHK-Cu has no FDA- or EMA-approved therapeutic indication. The topical literature and the hair combination trial's absence of reported adverse events concern their respective preparations and conditions. Long-term human injection safety remains unestablished. Reports of irritation and pigment changes deserve attention on their own terms.
Route and safety
For the systemic question, validated human exposure data are missing. For topical experiences, the side-effects page distinguishes anecdotal reports from the available clinical and laboratory findings.
GHK-Cu and vitamin C
Strongly acidic ascorbic acid can disrupt the copper complex; other low-pH actives may destabilize it or compete for copper. The topical-delivery research treats formulation stability as a chemical question. The chemistry interests me; arranging someone's skin-care plan requires a different kind of assessment.
Can GHK-Cu cross the blood-brain barrier?
Human brain entry has not been established. The pain-related behaviour experiment used free GHK in rats and recorded reduced aggressive-defensive behaviour. A behavioural response in rats cannot locate or quantify copper-bound GHK-Cu in a human brain.
Is GHK-Cu anti-aging?
The skin-regeneration review reports plasma GHK declining from about 200 ng/mL at age 20 to about 80 ng/mL by age 60. The gene-expression work describes cell and database signatures. Neither establishes that restoring a blood level reverses aging in people. I'd reserve enthusiasm for the particular skin outcomes that have actually been measured.